Project: Developing a complete cervical cancer screening solution based on first-void urine self-sampling
| Acronym | CASUS (Reference Number: 12396) |
| Duration | 01/10/2018 |
| Project Topic | We want to develop the first complete molecular screening solution for cervical cancer (CC), based on standardized self-collected first-void urine to maximize screening participation throughout the EU. CASUS will result in a next-generation user-friendly first-void urine collector, combined with an integrated diagnostic approach for 1) detection of human papillomavirus (HPV) infection and 2) triage after a HPV+ result to identify women with CC or precursor lesions in need of colposcopy. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 9 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Self-screen B.V. | Coordinator | Netherlands |
| 2 | Novosanis | Partner | Belgium |